Related Experiment Video
Updated: Jun 12, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Potential pitfalls in the design and reporting of clinical trials
Matthew R Sydes1, Ruth E Langley
1Cancer Group, Medical Research Council Clinical Trials Unit, London, UK. matthew.sydes@ctu.mrc.ac.uk
The Lancet. Oncology
|June 12, 2010
Summary
This guide helps early-career researchers avoid common pitfalls in designing and conducting randomized controlled trials (RCTs). Proper trial design is crucial for generating reliable evidence-based medicine and meaningful research conclusions.
Area of Science:
- Clinical Trials
- Evidence-Based Medicine
- Research Methodology
Background:
- Randomized controlled trials (RCTs) are the cornerstone of evidence-based medicine.
- Successful RCTs require meticulous design and awareness of potential challenges.
- Early-career researchers often face avoidable pitfalls in trial design.
Purpose of the Study:
- To guide novice researchers in designing effective randomized controlled trials.
- To highlight common and preventable errors in trial design and execution.
- To enhance the quality and impact of medical research.
Main Methods:
- Focuses on critical aspects of trial design.
- Covers scientific idea assessment, trial structure, and duration.
- Includes guidance on data analysis and reporting standards.
Main Results:
- Identifies common pitfalls in trial design.
- Provides strategies for avoiding these issues.
- Aims to improve the success rate of clinical trials.
Conclusions:
- Awareness of potential pitfalls is key to successful trial design.
- Avoiding common errors maximizes the chances of generating meaningful evidence.
- This paper serves as a practical resource for researchers starting their careers.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:29Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is: